Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2 4 mg, an Italian real-world study
Pampanelli S, Terzoni S, Pantanetti P, et al.
Diabetes Obes Metab. Pub. online 23 Feb 2026.
Leggi


